Dr. Agarwal shares LITESPARK-013 results: Optimal dose of belzutifan is 120mg
In this podcast, Dr. Neeraj Agarwal (US), presidential endowed chair of cancer research at the Huntsman Cancer Institute, University of Utah, shares the results of the LITESPARK-013 Phase 2 trial - "S...
8 Marras 20234min
Prof. Roberto Iacovelli: Drug interruptions in mRCC IO-TKI (Avelumab and axitinib) is safe and may reduce toxicity and cost for the treatment
In this podcast, UROONCO RCC associate editor Dr. Teele Kuusk (GB) talks with Prof. Roberto Iacovelli (IT), Gostino Gemelli University Polyclinic, Rome, about the abstract he presented at ESMO 2023, "...
1 Marras 20236min
Prof. Albiges shares LITESPARK-005 study results: Belzutifan improves PFS in pretreated mRCC patients
In this podcast, UROONCO RCC associate editor Dr. Teele Kuusk (GB) talks with medical oncologist Prof. Laurence Albiges (FR), Head of the Department of Oncology at Gustave Roussy, about her abstract: ...
28 Loka 20235min
ESMO 2023 special: Dr. Van Der Heijden talks about the phase 3 CheckMate 901 trial results
In this podcast from ESMO 2023, UROONCO BCa associate editor Dr. Laura Mertens (NL) talks with Dr. Michiel Van Der Heijden (NL) on his abstract “Nivolumab plus gemcitabine-cisplatin versus gemcitabine...
24 Loka 20238min
ESMO 2023 special: Prof. Powles shares positive KEYNOTE-A39 trial results
In this special podcast, UROONCO BCa chief editor Dr. Benjamin Pradere (FR) talks with Prof. Thomas Powles (GB) about the positive results of the EV-302/KEYNOTE-A39 trial that were announced at ESMO 2...
22 Loka 20239min
Special series: Artificial intelligence application for urologic cancer detection and classification
In 'Episode 4' of the special podcast series on "Uro-oncologic surgery driven by new technologies", Prof. Ricardo Autorino (IT) talks to expert Assoc. Prof. Giovanni Enrico Cacciamani (US) about Artif...
7 Loka 202322min
Special series: 3D models for kidney cancer with caval thrombous
In 'Episode 3' of the podcast series on "Uro-oncologic surgery driven by new technologies", Prof. Ricardo Autorino (IT) talks to expert Dr. Inés Rivero Belenchón (ES) about 3D models for kidney cancer...
30 Syys 202312min
Dr. Marra talks to Prof. Ahmed on focal therapy for low- or intermediate-risk PCa
In this podcast, UROONCO PCa associate editor Dr. Giancarlo Marra (IT) talks to Prof. Hashim Ahmed (GB) after his presentation at UROonco23 on focal therapy for low- or intermediate-risk prostate canc...
27 Syys 202312min
